PHARMAGEST INTERACTIVE : Noviatek is the gold award winner during the 2018 Hong Kong Electronics Fair
Villers-lès-Nancy, October 16, 2018 - 06:00 pm(CET)
NOVIATEK IS THE 2018
HKEIA OVERALL PRODUCT OF THE YEAR
AND Gold Award Winner
On 15th October 2018, The Hong Kong Electronic Industries Association announced NOVIATEK won the prestigious PRODUCT OF THE YEAR AWARD and the GOLD AWARD in the annual HKEIA(HONG KONG ELECTRONIC INDUSTRIES ASSOCIATION) Award..
The award, for outstanding innovation and technology, was given for the Noviatek's NoviaCare Artificial Intelligence Seniors health box by Pharmagest, in the category of safety and security and the overall Product of the year Award.
The HKEIA award was held during the 2018 Hong Kong Electronics Fair (Autumn Edition), the world's second largest electronics show: it recognizes and rewards excellence in product design, technology, reliability and innovation and is fully endorsed by the Hong Kong Trade Development Council, Hong Kong Productivity Council and the Hong Kong Science and Technology Park Corporation.
At a gala dinner during the Hong Kong Electronics Fair, the jury selected the innovative consumer product for great value to the lives of elderly people living home alone and overall effectiveness for the health system.
The Noviacare box helps seniors stay safe in their home by detecting and recognizing, through advanced sensors and AI, negative changes in their living patterns and sending alarms to their families or caregivers when needed. The box works autonomously and is able to interact through voice and sounds with the persons at home and helps them feel that they are secure, that their privacy is respected and that, when help is required, their families or caregivers are immediately notified.
The device is not intrusive, does not require an internet connection and is easy to install in the home (wireless, Plug&Play).
Noviatek is a subsidiary of the Pharmagest Group (Listed on Euronext Paris(TM) - Compartment B - ISIN: FR0012882389 - Reuters: PHA.PA - Bloomberg: PMGI FP)
Mark DE SIMONE, Director of International Development for the Pharmagest Group and its parent company La Cooperative Welcoop, together with Regis CIRE, Co-Founder and Director of Noviatek accepted the award in front of a full audience of members of the Hong Kong Electronic Industries Association.
Régis CIRE declared: "Our company uses the latest technologies to develop reliable solutions for seniors. To age well at home is to adapt your home first. Our solutions make it easy and secure. The Noviacare(TM) assistance system required over 4 years of R&D, in partnership with laboratories, universities and associations and we are proud and honored to receive this prestigious award. "
Mark DE SIMONE, commented: "this prize, during the global trade show, has attracted companies from all over the world, to introduce and distribute NoviaCare(TM) in their markets. This paves the way for a faster and broader deployment of the Group Pharmagest's innovations in health technology across the world."
PHARMAGEST INTERACTIVE financial calendar reminder:
- Publication of Q3 2018 revenue: 14 November 2018
- Publication of FY 2018 annual revenue: 14 February 2019
About Pharmagest Group:
Pharmagest Group is the French pharmacy information technology leader, with a market share of more than 42% and more than 1.000 employees. The Group's strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.
To roll out this strategy, Pharmagest Group has developed specialized businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace.
These businesses are grouped within four divisions: Solutions for Pharmacy Division - Europe; Solutions for Health and Social Care Facilities; Solutions for e-Health; and FinTech.
Listed on Euronext Paris(TM) - Compartment B
Indices: CAC ® SMALL and CAC ® All-Tradable par inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR 0012882389 - Reuters: PHA.PA - Bloomberg: - PMGI FP
For all the latest news go to www.pharmagest.com